Pituitary ablation, insulin dosage, and course of diabetic retinopathy.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D001794:Blood Pressure; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D003404:Creatinine / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000628:therapy*; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007016:Hypophysectomy; D007328:Insulin / Q000008:administration & dosage*; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D010902:Pituitary Gland / Q000528:radiation effects; D011374:Progesterone / Q000627:therapeutic use; D011830:Radiation Effects; D012173:Retinitis; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000627:therapeutic use; D014785:Vision, Ocular; D014792:Visual Acuity
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006063:Chorionic Gonadotropin; D004967:Estrogens; D007328:Insulin; D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D011374:Progesterone; D003404:Creatinine; D006854:Hydrocortisone